Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, Bellesoeur A, Servois V, Hequet D, Laas E, Kirova Y, Cabel L, Pierga JY; Institut Curie Breast Cancer and COVID Group; Bozec L, Paoletti X, Cottu P, Bidard FC. Vuagnat P, et al. Among authors: cabel l. Breast Cancer Res. 2020 May 28;22(1):55. doi: 10.1186/s13058-020-01293-8. Breast Cancer Res. 2020. PMID: 32460829 Free PMC article.
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
Ramtohul T, Cabel L, Paoletti X, Chiche L, Moreau P, Noret A, Vuagnat P, Cherel P, Tardivon A, Cottu P, Bidard FC, Servois V. Ramtohul T, et al. Among authors: cabel l. Front Oncol. 2020 Sep 3;10:1560. doi: 10.3389/fonc.2020.01560. eCollection 2020. Front Oncol. 2020. PMID: 33014804 Free PMC article.
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Alhenc-Gelas M, Cabel L, Berger F, Delaloge S, Frenel JS, Levy C, Firmin N, Ladoire S, Desmoulins I, Heudel PE, Dalenc F, Loirat D, Dubot C, Vuagnat P, Deluche E, Mokdad-Adi M, Patsouris A, Annic J, Djerroudi L, Lavigne M, Pierga JY, Coppo P, Bidard FC. Alhenc-Gelas M, et al. Among authors: cabel l. Breast Cancer Res. 2021 Jan 19;23(1):9. doi: 10.1186/s13058-021-01386-y. Breast Cancer Res. 2021. PMID: 33468209 Free PMC article.
Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanoma.
Ramtohul T, Cohen A, Rodrigues M, Piperno-Neumann S, Cabel L, Cassoux N, Lumbroso-Le Rouic L, Malaise D, Gardrat S, Pierron G, Mariani P, Servois V. Ramtohul T, et al. Among authors: cabel l. Br J Cancer. 2022 Jul;127(2):258-267. doi: 10.1038/s41416-022-01793-8. Epub 2022 Mar 26. Br J Cancer. 2022. PMID: 35347325 Free PMC article.
Invasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?
Djerroudi L, Cabel L, Bidard FC, Vincent-Salomon A. Djerroudi L, et al. Among authors: cabel l. J Natl Cancer Inst. 2022 Nov 14;114(11):1434-1436. doi: 10.1093/jnci/djac159. J Natl Cancer Inst. 2022. PMID: 36239762 No abstract available.
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Seban RD, Arnaud E, Loirat D, Cabel L, Cottu P, Djerroudi L, Hescot S, Loap P, Bonneau C, Bidard FC, Huchet V, Jehanno N, Berenbaum A, Champion L, Buvat I. Seban RD, et al. Among authors: cabel l. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4024-4035. doi: 10.1007/s00259-023-06394-y. Epub 2023 Aug 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 37606858
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Cabel L, Carton M, Cheaib B, Pierga JY, Dalenc F, Mailliez A, Levy C, Jacot W, Debled M, Leheurteur M, Desmoulins I, Lefeuvre C, Gonçalves A, Uwer L, Ferrero JM, Eymard JC, Petit T, Mouret-Reynier MA, Perrocheau G, Piot I, Pérol D, Simon G, Lerebours F. Cabel L, et al. Breast Cancer Res Treat. 2019 Jan;173(2):397-406. doi: 10.1007/s10549-018-5017-2. Epub 2018 Oct 24. Breast Cancer Res Treat. 2019. PMID: 30357526
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Vasseur A, Cabel L, Tredan O, Chevrier M, Dubot C, Lorgis V, Jacot W, Goncalves A, Debled M, Levy C, Ferrero JM, Jouannaud C, Luporsi E, Mouret-Reynier MA, Dalenc F, Lemonnier J, Savignoni A, Tanguy ML, Bidard FC, Pierga JY. Vasseur A, et al. Among authors: cabel l. Angiogenesis. 2020 May;23(2):193-202. doi: 10.1007/s10456-019-09697-7. Epub 2019 Nov 26. Angiogenesis. 2020. PMID: 31773439
73 results